Article info

Download PDFPDF
Extended report
Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): results of a multicentre, dose escalation, randomised, single-blind, placebo-controlled phase Ib/IIa clinical trial

Authors

  1. Correspondence to Dr José M Álvaro-Gracia, Hospital Universitario de La Princesa, Unidad de Terapias Biológicas, Servicio de Reumatología, IIS-IP, Madrid 28006, Spain; jalvarogracia{at}gmail.com
View Full Text

Citation

Álvaro-Gracia JM, Jover JA, García-Vicuña R, et al
Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): results of a multicentre, dose escalation, randomised, single-blind, placebo-controlled phase Ib/IIa clinical trial

Publication history

  • Received November 18, 2015
  • Accepted May 17, 2016
  • First published June 7, 2016.
Online issue publication 
December 09, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.